Centrum Medyczne Justmed Sp. z o.o.
- Address
- Ul. Marymoncka 14/ U1 U2, 01-696 Warsaw, Poland
Centrum Medyczne Justmed Sp. z o.o.
Centrum Medyczne Justmed Sp. z o.o. is a clinical research facility specializing in advanced therapeutic interventions across multiple medical disciplines. The center demonstrates particular expertise in evaluating novel biologic therapies and innovative pharmaceutical approaches for chronic inflammatory and cardiovascular conditions.
- Psoriatic arthritis management with biologic DMARDs and emerging immunomodulatory agents
- Cardiovascular disease prevention, particularly in patients with elevated lipoprotein(a) levels
- Primary prevention trials targeting first major cardiovascular events in high-risk populations
The research center is actively engaged in pivotal international trials investigating subcutaneous biologic therapies for psoriatic arthritis and RNA interference therapeutics for cardiovascular risk reduction. Their participation in multi-phase studies evaluating both efficacy and safety outcomes positions them at the forefront of translating cutting-edge pharmaceutical innovations into clinical practice for patients with complex rheumatologic and metabolic conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 5 of 7 therapeutic areas and 11 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centrum Medyczne Justmed Sp. z o.o.
lock Showing 1 of 12 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Open-Label Extension Study to Evaluate the Long-Term Safety, Tolerability, and Efficacy of Subcutaneous Sonelokimab in Participants With Psoriatic Arthritis | MoonLake Immunotherapeutics AG | Phase III | Not Yet Recruiting | — | — |
IMP list
lock Showing 1 of 11 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Efgartigimod Alfa | 2 | Unknown | 2025-04-15 | 2025-04-15 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.